| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHI1
|
Abelson helper integration site 1
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
AR
|
androgen receptor
|
|
AURKA
|
aurora kinase A
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BATF2
|
basic leucine zipper transcription factor, ATF-like 2
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD247
|
CD247 molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CDC42
|
cell division cycle 42
|
|
CDH13
|
cadherin 13
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPZ
|
CCAAT/enhancer binding protein (C/EBP), zeta
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DDX43
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DUSP12
|
dual specificity phosphatase 12
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
FBXO5
|
F-box protein 5
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOXM1
|
forkhead box M1
|
|
FOXO3
|
forkhead box O3
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GATA2
|
GATA binding protein 2
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GPX1
|
glutathione peroxidase 1
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HDC
|
histidine decarboxylase
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOXA11
|
homeobox A11
|
|
HOXA4
|
homeobox A4
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IFITM1
|
interferon induced transmembrane protein 1
|
|
IFNG
|
interferon, gamma
|
|
IL10
|
interleukin 10
|
|
IL1RAP
|
interleukin 1 receptor accessory protein
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL33
|
interleukin 33
|
|
IL6
|
interleukin 6
|
|
IRF8
|
interferon regulatory factor 8
|
|
JAK2
|
Janus kinase 2
|
|
JUNB
|
jun B proto-oncogene
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LCN2
|
lipocalin 2
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIG3
|
ligase III, DNA, ATP-dependent
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LTC4S
|
leukotriene C4 synthase
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAFF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F
|
|
MAFG
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCPH1
|
microcephalin 1
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MIR155
|
microRNA 155
|
|
MIR199B
|
microRNA 199b
|
|
MIR21
|
microRNA 21
|
|
MIR219A2
|
microRNA 219a-2
|
|
MIR22
|
microRNA 22
|
|
MIR31
|
microRNA 31
|
|
MIR564
|
microRNA 564
|
|
MIR633
|
microRNA 633
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NME2
|
NME/NM23 nucleoside diphosphate kinase 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NOV
|
nephroblastoma overexpressed
|
|
OAZ1
|
ornithine decarboxylase antizyme 1
|
|
ODF4
|
outer dense fiber of sperm tails 4
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PHF6
|
PHD finger protein 6
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PHLPP2
|
PH domain and leucine rich repeat protein phosphatase 2
|
|
PLK1
|
polo-like kinase 1
|
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
RAB38
|
RAB38, member RAS oncogene family
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RASEF
|
RAS and EF-hand domain containing
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RBM15
|
RNA binding motif protein 15
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
RUNX1
|
runt-related transcription factor 1
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SESN3
|
sestrin 3
|
|
SET
|
SET nuclear proto-oncogene
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SHH
|
sonic hedgehog
|
|
SIRT1
|
sirtuin 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SPAG9
|
sperm associated antigen 9
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SQSTM1
|
sequestosome 1
|
|
ST2
|
suppression of tumorigenicity 2
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
SYK
|
spleen tyrosine kinase
|
|
TBCE
|
tubulin folding cofactor E
|
|
TEX101
|
testis expressed 101
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THAP11
|
THAP domain containing 11
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TKTL1
|
transketolase-like 1
|
|
TNF
|
tumor necrosis factor
|
|
TP53
|
tumor protein p53
|
|
UGCG
|
UDP-glucose ceramide glucosyltransferase
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
